Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.82
1.86
NAV
₹492.08
₹38.00
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹8264.71 Cr
₹6455.55 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
-1.49%
-1.13%
3 Year
20.10%
25.33%
5 Year
14.06%
16.15%
Equity
97.37%
97.87%
Cash
2.62%
2.13%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.02% |
Lupin Ltd. | 7.36% |
Divi's Laboratories Ltd. | 6.58% |
Cipla Ltd. | 6.39% |
Dr. Reddy's Laboratories Ltd. | 6.02% |
Apollo Hospitals Enterprise Ltd. | 5.53% |
Vijaya Diagnostic Centre Ltd. | 3.71% |
Medplus Health Services Ltd. | 3.54% |
Ajanta Pharma Ltd. | 3.21% |
Sai Life Sciences Ltd. | 2.81% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018